late-stage, persistent infection with Borrelia burgdorferi or
complications related to the infection or with other strains of
Borrelia, including B. miyamotoi, B. mayonii, B. garinii and B.
afzelii, that are recognized by the Centers for Disease Control
and Prevention as a cause of Lyme disease. The term includes
infection that meets the surveillance criteria established by
the Centers for Disease Control and Prevention and other acute
and persistent manifestations of the infection as determined by
a health care practitioner.
"Related tick-borne disease." The presence of signs or
symptoms compatible with infection with bartonella,
babesiosis/piroplasmosis, anaplasmosis, ehrlichiosis, Rocky
Mountain spotted fever, rickettsiosis, Powassan or other tick-
transmissible illness or complications related to the
infections. The term does not include Lyme disease.
Section 3. Continuing education requirement.
(a) General rule.--A licensing board shall require that a
licensee complete at least two hours of continuing education in
the assessment and diagnosis of and treatment options for Lyme
disease and other related tick-borne diseases as a portion of
the total continuing education required for license renewal.
(b) Content.--A licensing board shall establish the content
of continuing medical education required under this section. The
content shall address, at a minimum, the most current, evidence-
based research on tick data/pathogens Statewide, patient profile
and symptom presentation in regards to assessment and diagnosis,
current diagnostic options and current treatment options and
prevention.
(c) Input.--In establishing the content required for
continuing medical education required under this section, the
20230SB0233PN0200 - 3 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30